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Background: White blood cell count is an independent risk factor for cardiovascular disease. Several lifestyle and 
metabolic factors such as cigarette smoking and obesity are known to be associated with an elevated white blood 
cell count. However, the joint effect of cigarette smoking and obesity on white blood cell count has not yet been fully 
described.
Methods: We explored the joint effect of cigarette smoking and obesity on white blood cell count using multiple lo-
gistic regression analyses after adjusting for confounding variables in a population-based, cross-sectional study of 
416,065 Korean adults.
Results: Cigarette smoking and body mass index have a dose-response relationship with a higher white blood cell 
count, but no synergistic interaction is observed between them (men, P for interaction=0.797; women, P for inter-
action=0.311). Cigarette smoking and body mass index might have an additive combination effect on high white 
blood cell count. Obese male smokers were 2.36 times more likely and obese female smokers 2.35 times more likely 
to have a high white blood cell count when compared with normal body mass index non-smokers.
Conclusion: Cigarette smoking and body mass index are independently associated with an elevated white blood 
cell count in both men and women.
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introDUCtion
Several lifestyle factors, including cigarette smoking, alcohol intake, 
and lack of regular exercise, along with metabolic factors such as obe-
sity, type 2 diabetes, hypertension, and dyslipidemia, are known to be 
associated with the risk of atherosclerotic cardiovascular disease 
(CVD). Although the pathogenesis of atherosclerosis and its relation to 
CVD remains unclear, increasing evidence suggests that arterial in-
flammation may play a key role in the process of atherosclerosis.1,2) A 
high white blood cell (WBC) count has been shown to be an indepen-
dent predictor of cardiovascular events. Thus, early detection of an el-
evated WBC count may be important in predicting subsequent CVD 
morbidity and mortality.
 The WBC count, widely evaluated in standard clinical practice, is a 
nonspecific marker of inflammation and may play an important role 
in the pathogenesis of arterial injury and the atherosclerotic process.1) 
Numerous studies in recent decades have revealed that lifestyle and 
metabolic risk factors are related to an elevated WBC count. For exam-
ple, it has been demonstrated that current smokers have higher WBC 
counts than people who have never smoked.3,4) In addition, alcohol in-
take,5) physical inactivity,6) body mass index (BMI),7) hypertension,8) 
type 2 diabetes,9) and dyslipidemia10) have been shown to be associat-
ed with an elevated WBC count.
 The independent effects of lifestyle and metabolic factors on WBC 
count have been reported in numerous epidemiological studies.3-10) It 
may be more important whether there is an additive or synergistic ef-
fect of lifestyle and metabolic factors on inflammation causing cardio-
metabolic diseases. However, there has been limited exploration of the 
combined or interactive effect of lifestyle factors and metabolic factors 
on WBC count. Therefore, we investigated the possible interactive ef-
fects of cigarette smoking and BMI on WBC count in a large, popula-
tion-based, cross-sectional cohort of 416,065 Koreans (105,505 men 
and 309,560 women), who underwent medical examination at the re-
quest of the National Health Insurance Corporation between 1993 and 
1995.
MetHoDs
1. study Population
The Korean Cancer Prevention Study (KCPS) is a prospective cohort 
study designed to assess cancer risk factors by examining disease inci-
dence, mortality, and hospital admissions. The KCPS cohort is primar-
ily composed of government employees, teachers, and their depen-
dents insured by the Korean Medical Insurance Corporation from 
1992 through 1995. Subjects had at least one medical examination and 
completed a questionnaire during that period. The KCPS cohort in-
cludes 1,329,525 Koreans (846,907 men and 482,618 women) from 30 
to 95 years of age who met the above selection criteria. This study did 
not include insured workers in its retrospective analysis because the 
WBC count of these individuals was not recorded during their medical 
examination. Therefore, the current analysis was limited to insured 
workers’ family dependents in 1993 and 1995 (n=448,978). Then, 
11,332 subjects whose WBC counts were less than 3,000 cells/mm3 or 
more than 11,000 cells/mm3 were also excluded from this analysis. To 
avoid confounding the association among smoking, BMI, and WBC 
count, 13,448 subjects who reported a history of cancer, CVD, respira-
tory disease, renal disease, and liver disease were also excluded. Addi-
tionally, 9,146 subjects with missing data on any covariate information 
or who had an extremely low BMI (<16.0 kg/m2) or short stature (<130 
cm) were excluded from the study. After these exclusions, 416,065 par-
ticipants (105,505 men and 309,560 women) between the ages of 30 
and 95 years were included in the final analyses.
2. Data Collection
Medical examinations were performed according to a standardized 
procedure and were conducted by medical staff at local hospitals. In 
the 1993 and 1995 questionnaires, participants were asked about their 
smoking habits and other health-related behaviors. Body weight and 
height were measured with participants wearing light clothing without 
shoes to the nearest 0.1 kg and 0.1 cm, respectively. Participants were 
also asked if they were currently being treated for cancer or other dis-
eases. If so, they were asked for the date of diagnosis. The completed 
questionnaires were reviewed by trained staff and then entered into a 
database. WBC count and serum levels of glucose and total cholesterol 
were measured under fasting conditions for routine clinical purposes. 
Each hospital had internal and external quality control procedures di-
rected by the Korean Association of Laboratory Quality Control. Smok-
ing exposure was categorized according to smoking status (non-smok-
ers, ex-smokers, and current smokers) and the number of cigarettes 
per day among current smokers (1 to 9, 10 to 19, and 20 or more). BMI 
(kg/m2) was calculated as the ratio of weight (kg) and height (m2), and 
was divided into seven categories: <18.5, 18.5–19.9, 20.0–21.4, 21.5–
22.9, 23.0–24.9, 25.0–26.9, and ≥27.0 kg/m2. The total daily alcohol 
consumption was expressed as the number of glasses per week in rela-
tion to Korea’s most popular alcoholic beverage, ‘soju.’ One glass of 
soju contains about 12 g of ethanol. Alcohol consumption per day was 
categorized as follows: none (0 g), light (1–14.9 g), and moderate to 
heavy (15 g or more). Participants were also asked to report if they ex-
ercised regularly. WBC counts were quantified using automated blood 
cell counters (Beckman Coulter, Fullerton, CA, USA) in hospital labo-
ratories. Fasting serum glucose and total cholesterol levels were ana-
lyzed using enzymatic methods with an automatic chemistry analyzer 
(Hitachi 7600-110; Hitachi, Tokyo, Japan). Impaired fasting glucose 
was defined as ≥100 fasting plasma glucose level <126 mg/dL. Diabe-
tes was defined from self-reported history or when the fasting serum 
glucose level was ≥126 mg/dL. Pre-hypertension was defined as a sys-
tolic pressure of 120–139 mm Hg or a diastolic pressure of 80–89 mm 
Hg. Hypertension was defined from self-reported history or when sys-
tolic blood pressure was ≥140 mm Hg or diastolic blood pressure was 
≥90 mm Hg. Hypercholesterolemia was defined when the fasting se-
rum cholesterol level was ≥200 mg/dL. Because the study involved 
routinely collected medical data, it was not necessary to obtain indi-
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vidual participant consent.
3. statistical Analysis
All statistical analyses were conducted in a gender-specific manner. 
Age- and BMI-adjusted means of the WBC count for each category of 
smoking exposure were calculated. The cutoff point for a high WBC 
count was determined as 7,500 cells/mm3, which corresponded to the 
75th percentile.11) Multiple logistic regression analysis was used to 
compute odds ratios (ORs) and 95% confidence intervals (CIs) for high 
WBC counts, and the 95% CIs were examined according to the five cat-
egories of smoking exposure, seven categories of BMI, three categories 
of fasting serum glucose levels (normal, impaired fasting glucose, and 
type 2 diabetes), three categories of blood pressure (normal, pre-hy-
pertension, and hypertension), and four categories of serum choles-
terol levels (<160, 160–199, 200–239, and ≥240 mg/dL). Similarly, age-
adjusted proportions of high WBC count per 1,000 persons were cal-
culated and directly standardized to the age distribution of the Korean 
population in 1995. Further, we explored a possible interactive effect 
among smoking status, BMI, and gender-influenced metabolic risks 
on WBC count by using multiple logistic regression analysis. The po-
tential interaction between cigarette smoking and BMI was tested by 
the multiplicative method. All analyses were conducted using SAS sta-
tistical software ver. 8.2 (SAS Institute Inc., Cary, NC, USA). All statisti-
cal tests were two-sided and statistical significance was determined at 
P-value <0.05.
resUlts
Table 1 shows the general characteristics of the study population, 
which consisted of about three times as many women as men. The 
mean BMI (kg/m2) of the study population was 22.7 for men and 24.0 
for women. About 19.9% of men and 32.0% of women had a BMI ≥25.0 
kg/m2, and 7.2% of men and 16.2% of women had a BMI ≥27.0 kg/m2. 
Both cigarette smoking and alcohol use were substantially more com-
mon in men than in women. Systolic blood pressure and levels of fast-
ing serum glucose and total cholesterol were also higher in men than 
in women.
 Figure 1 shows the age-adjusted means of WBC count (cells/mm3) 
according to BMI categories and smoking history. The mean WBC 
count was higher in ever-smokers among both men and women. 
Moreover, the mean WBC counts gradually increased with increasing 
BMI levels irrespective of smoking status in both men and women (all 
P for trends <0.001).
 Table 2 shows the effects of lifestyle risks (smoking exposure, alcohol 
intake, and lack of regular exercise) and metabolic risks (high BMI, 
fasting serum glucose levels, blood pressure, and total cholesterol lev-
els) on high WBC count. The findings show that smoking exposure 
had a strong, positive, dose-response tendency in men and women. 
Men and women who smoked 20 or more cigarettes per day were 2.34 
times and 2.20 times more likely to have a high WBC count compared 
with non-smokers, respectively. Regular exercise had an inverse asso-
ciation with a high WBC count in both men and women, whereas light 
alcohol consumption (<15 g/d) had an inconsistent association with 
WBC count among both men and women. All four metabolic risks in-
cluded in our analyses were also significantly associated with a high 
WBC count. The relative risks for high WBC count increased progres-
sively with increasing BMI levels in both men and women. The associ-
ation between high serum glucose levels and high WBC count was 
also significant in men and women. In addition, individuals with hy-
Table 1. Clinical characteristics of the study population
Characteristic
Men 
(n=105,505)
Women 
(n=309,560)
Age (y) 61.3±7.6 53.9±9.2
Body mass index (kg/m2) 22.7±2.8 24.0±3.1
Systolic blood pressure (mm Hg) 129.2±20.8 125.2±20.6
Fasting serum glucose (mg/dL) 96.9±33.2 92.9±27.0
White blood cell count (cells/mm3) 7,103±1,623 6,491±1,515
Total cholesterol (mg/dL) 190.7±38.8 199.5±39.6
Alcohol consumption (g/d)
   0 37.4 86.4
   0.1–14.9 61.8 13.5
   ≥15.0 0.8 0.0
Smoking status
   Non-smokers 20.3 92.2
   Ex-smokers 25.4 2.5
   Current smokers (cigarettes/d)
      1–9 15.7 2.9
      10–19 22.4 1.7
      ≥20 16.1 0.7
Regular exercise 31.2 18.6
Hypertension* 46.3 37.7
Type 2 diabetes† 8.7 5.5
Values are presented as mean±standard deviation or %, unless otherwise indicated.
*Defined as systolic blood pressure 140 mm Hg and/or diastolic blood pressure ≥90 
mm Hg or a history of the disorder. †Defined as fasting serum glucose level ≥126 
mg/dL or a history of the disorder.
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Figure 1. Age-adjusted means of WBC count (cells/mm3) according to BMI category 
and smoking history. WBC, white blood cell; BMI, body mass index.
A-Ra Cho, et al. • Determinants of White Blood Cell Count78  www.kjfm.or.kr
https://doi.org/10.4082/kjfm.2017.38.2.75
pertension and pre-hypertension had significant associations with a 
high WBC count among both men and women. Moreover, the associa-
tion between a high serum cholesterol level and high WBC count was 
also significant in both men and women.
 We explored patterns of the joint effect of cigarette smoking and 
BMI on WBC count. Table 3 shows the OR estimates for the strata as 
defined by nine pairs of three categories of smoking status and three 
categories of BMI. The highest OR for a high WBC count was observed 
among current smokers who had a BMI ≥25.0 kg/m2. Obese male 
smokers were 2.36 times more likely and obese female smokers were 
2.35 times more likely to have a high WBC count when compared with 
non-smokers with a normal BMI. Therefore, cigarette smoking and 
BMI seem to have an additive combined effect on high WBC count but 
no synergistic interaction (men, P for interaction=0.797; women, P for 
interaction=0.311).
Table 2. Age-adjusted proportion* per 1,000 persons and OR† for high WBC count‡ as a dependent variable and the associated factors as independent variables among men 
and women
Characteristic
Men (n=105,505) Women (n=309,560)
Age-adjusted proportion 
per 1,000 persons
Adjusted OR (95% CI)
Age-adjusted proportion 
per 1,000 persons
Adjusted OR (95% CI)
Lifestyle factors
   Smoking exposure
      Non-smokers 281.5 1.00 229.0 1.00
      Ex-smokers (cigarettes/d) 302.6 1.11 (1.06–1.16) 263.4 1.26 (1.20–1.33)
      1–9 389.2 1.59 (1.51–1.67) 318.9 1.67 (1.60–1.75)
      10–19 428.6 1.92 (1.84–2.01) 349.4 1.83 (1.73–1.94)
      ≥20 494.4 2.34 (2.23–2.46) 376.4 2.20 (2.01–2.41)
   Alcohol intake (g/d)
      Non-drinkers 365.8 1.00 231.6 1.00
      1–14.9 383.7 0.96 (0.93–0.99) 256.7 1.09 (1.06–1.12)
      ≥15.0 430.6 0.95 (0.80–1.12) NE NE
   Regular exercise
      No 389.8 1.00 250.3 1.00
      Yes 350.4 0.91 (0.88–0.94) 193.8 0.91 (0.89–0.93)
Metabolic factors
   BMI (kg/m2)
      <18.5 358.0 1.04 (0.96–1.12) 183.5 0.96 (0.90–1.02)
      18.5–19.9 338.1 1.00 187.6 1.00
      20.0–21.4 352.8 1.07 (1.02–1.14) 193.5 1.02 (0.98–1.06)
      21.5–22.9 363.1 1.15 (1.09–1.21) 211.3 1.11 (1.07–1.16)
      23.0–24.9 382.0 1.21 (1.16–1.28) 231.6 1.23 (1.18–1.28)
      25.0–26.9 403.4 1.31 (1.24–1.39) 256.0 1.39 (1.34–1.45)
      ≥27.0 427.5 1.32 (1.23–1.41) 299.6 1.64 (1.58–1.71)
   FSG (mg/dL)
      Normal 373.3 1.00 226.3 1.00
      Impaired fasting glucose§ 392.9 1.07 (1.01–1.12) 276.8 1.19 (1.15–1.23)
      Type 2 diabetesΙΙ 420.8 1.16 (1.11–1.22) 340.3 1.62 (1.56–1.67)
   Blood pressure (mm Hg)
      Normal 357.7 1.00 208.2 1.00
      Pre-hypertension¶ 374.7 1.06 (1.02–1.11) 230.4 1.09 (1.06–1.11)
      Hypertension** 395.6 1.11 (1.07–1.15) 261.3 1.20 (1.17–1.23)
   Total cholesterol (mg/dL)
      <160 331.5 1.00 193.3 1.00
      160–199 367.2 1.16 (1.12–1.22) 222.1 1.15 (1.12–1.18)
      200–239 401.9 1.32 (1.27–1.38) 248.2 1.25 (1.22–1.29)
      ≥240 436.5 1.46 (1.43–1.50) 286.1 1.44 (1.40–1.49)
OR, odds ratio; WBC, white blood cell; CI, confidence interval; NE, not estimated due to the small number of subjects; BMI, body mass index; FSG, fasting serum glucose; SBP, 
systolic blood pressure; DBP, diastolic blood pressure.
*The proportion per 1,000 persons is given, standardized according to the age distribution of Korea’s national population in 1995. †OR and 95% CIs from multiple logistic 
regression analysis after adjusting for age, smoking exposure, alcohol intake, BMI, fasting plasma glucose levels, blood pressure, and total cholesterol levels. ‡The cutoff for 
high WBC count was determined as 7,500 cells/mm3, which corresponded to the 75th percentile. §Defined as ≥100 fasting plasma glucose level <126 mg/dL. ΙΙDefined as 
FSG level of at least 126 mg/dL or a history of the disorder. ¶Defined as ≥120 SBP <140 mm Hg and/or ≥80 DBP <90 mm Hg. **Defined as SBP ≥140 mm Hg, DBP ≥90 mm 
Hg, or a history of the disorder. 
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DisCUssion
In this large, population-based cross-sectional study, cigarette smok-
ing and BMI were found to be independently associated with WBC 
count with an additive combined effect. Among lifestyle factors, ciga-
rette smoking had a prominent dose-response relationship with a high 
WBC count for both men and women. Our results also showed that 
the WBC count was high even in ex-smokers. This observed associa-
tion is in agreement with most recent studies on this topic. Kawada12) 
reported that the WBC count was higher in smokers and ex-smokers 
than in non-smokers, and elevated WBC counts were maintained for 
several years after cessation of smoking. The mechanism underlying 
the smoking-induced increase in WBC count remains unclear. Chron-
ic smoking stimulates the airway tract and may increase the WBC 
count.13) Light alcohol consumption (<15 g/d) decreased the OR for 
high WBC count in men, but not in women. Light alcohol consump-
tion and casual drinking, but not binge or heavy alcohol consumption, 
has been reported to have significant beneficial effects on inflammato-
ry markers.5) However, because our study did not distinguish between 
normal causal and binge drinking patterns, the association between 
alcohol consumption and WBC counts should be interpreted cau-
tiously. The OR for high WBC counts was also significantly decreased 
in both men and women who exercised regularly. Regular exercise has 
a beneficial and favorable impact on abdominal fat accumulation, 
blood pressure, insulin sensitivity, dyslipidemia, and inflammatory 
markers.6,14-17) Since WBC count is strongly influenced by body fat, it 
may be equally plausible that lower WBC counts are an intermediate 
consequence of the effect of exercise on reduced body fat tissue.
 Among metabolic factors, all four metabolic risks were found to be 
associated with high WBC counts among both men and women. The 
increase in WBC count according to BMI categories could also be ex-
plained by pro-inflammatory cytokines including interleukin-6 and 
tumor necrosis factor-a, which are expressed in adipose tissue and 
stimulate the WBC count.18) Hypertension and pre-hypertension were 
found to be significantly associated with the WBC count in both men 
and women. Recent studies have shown that the WBC count is associ-
ated with hypertension and high normal blood pressure.19,20) Although, 
the role of WBCs in hypertension remains unclear, inflammation may 
contribute to increasing microvascular capillary resistance, reducing 
endothelial reactivity, and increasing catecholamine levels, which can 
increase blood pressure.21-23)
 Obesity is a state in which there is an increased storage of fatty acids 
in the form of triglycerides in adipose tissue.24) Continuous release of 
fatty acid from stored triglycerides causes dyslipidemia and drives glu-
coneogenesis in the liver.25-27) Abdominal obesity, therefore, may be 
considered an important causal link between cardiovascular risk fac-
tors and high WBC count. In this regard, we explored the possible in-
teractive effect of cigarette smoking as a representative of lifestyle fac-
tors and BMI as a representative of metabolic factors; however, we 
found that cigarette smoking and BMI were independently associated 
with WBC count, and no interaction was found between them in the 
current study. Therefore, cigarette smoking and BMI might have had 
an additive combined effect on high WBC count but no synergistic in-
teraction.
 Our study has several limitations. First, only one measurement of 
WBC count, from a baseline examination, was included in the analy-
sis. Therefore, it was not possible to determine whether an acute, brief 
episode of inflammation or chronic inflammation was responsible for 
the correlation found in the current study. In addition, the effects of 
drugs such as aspirin or non-steroidal anti-inflammatory drugs, which 
can influence WBC count, were not fully adjusted for in the multiple 
logistic regression model. To minimize these errors, we excluded sub-
jects with a WBC count exceeding 11,000 cells/mm3. However, it is im-
portant to note that although the WBC count varies daily, a single 
measurement has been shown to predict risk for death and specific 
diseases, including cancer and CVD.28,29) Further, random misclassifi-
cation because of biological variability may result in the underestima-
tion of true associations, but this limitation does not explain our re-
sults. Second, information on the measurement of abdominal adiposi-
ty, such as waist circumference, was not available; consequently, we 
Table 3. Combined effect of cigarette smoking and BMI on high WBC count*
Variable 1 Variable 2
Men (n=105,505) Women (n=309,560)
Adjusted OR (95% CI)† P for interaction Adjusted OR (95% CI)† P for interaction
Smoking status BMI (kg/m2) 0.797 0.311
   Non-smoker    <23.0 1.00 1.00
   Non-smoker    23.0–24.9 1.09 (1.01–1.18) 1.16 (1.13–1.19)
   Non-smoker    ≥25.0 1.19 (1.10–1.28) 1.43 (1.40–1.47)
   Ex-smoker    <23.0 1.12 (1.05–1.19) 1.33 (1.22–1.45)
   Ex-smoker    23.0–24.9 1.28 (1.14–1.31) 1.45 (1.30–1.62)
   Ex-smoker    ≥25.0 1.37 (1.24–1.43) 1.70 (1.56–1.85)
   Current smoker    <23.0 1.82 (1.73–1.92) 1.86 (1.77–1.95)
   Current smoker    23.0–24.9 2.07 (1.96–2.21) 2.11 (1.96–2.28)
   Current smoker    ≥25.0 2.36 (2.21–2.51) 2.35 (2.19–2.51)
BMI, body mass index; WBC, white blood cell; OR, odds ratio; CI, confidence interval.
*The cutoff points of high WBC count were determined as 7,500 cells/mm3, which corresponded to the 75th percentile. †OR and 95% CI from multiple logistic regression 
analysis after adjusting for age, alcohol intake, regular exercise, fasting serum glucose, blood pressure, and total cholesterol. 
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could not determine whether the increased WBC count associated 
with increased BMI depended on overall adiposity, specific adipose 
tissue, or a distribution pattern. Lastly, the study population, particu-
larly the older population, might not be representative of the general 
population in Korea. However, since the sample size was quite large, 
we were able to investigate the relationship between a wide range of 
lifestyle and metabolic factors and WBC count. Because of these ad-
vantages, we found that each metabolic factor, even in the high normal 
range, was associated with WBC count.
 In conclusion, our study demonstrated that cigarette smoking and 
BMI were independently associated with high WBC count, showing an 
additive combined effect.
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